Definitive Contract 75F40123C00191
Award Date
9/22/23
Potential Completion Date
9/29/25
Potential Value
$634K
Federal Agency
Food and Drug Administration
Awardee
University Of Liverpool
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Two Step
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price federal contract award to the University of Liverpool, a leading UK research institution, for $9,412,272.00 to characterize severe coronavirus infections. The contract was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, on September 10, 2020, with a completion date of September 14, 2025. The contract does not have a set-aside designation. Based on the University of Liverpool's expertise in areas such as infectious diseases, immunology, and...
This is a $629,799.52 federal contract awarded by the Food and Drug Administration (FDA) to Duke University, a private university and non-profit organization. The contract is for a project titled "Bridging Novel Laboratory Animal and Hollow Fiber Infection Models to Evaluate Central Nervous System Penetration of Drugs in Infants." The contract is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of September 29, 2020. There was no set-aside...
This is a $400,000.00 Firm Fixed Price Definitive Contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan. The contract is intended to advance the science of in vitro, animal model, pharmacokinetic studies, and/or real-world evidence studies to facilitate drug development, including studies focused on antimicrobial resistance and drug development for specific pathogens. This contract is not associated with a set-aside designation. The contract work...
<p>This is a firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Sequoia Research Products LTD, a foreign-owned for-profit organization, for a study on drug repositioning. The contract has a ceiling value of $124,852.00 and an ultimate completion date of October 17, 2015. The contract is not set aside for any specific type of business. No further details about a larger contract vehicle are provided.</p>
This is a $61,418 firm fixed price contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the University of Maryland, Baltimore (UMB) on July 29, 2020. The contract is for the manufacture of an in vitro component to evaluate generic and new animal drug formulations that are not systemically absorbed. The contract has no set-aside designation and is scheduled for completion on June 30, 2023. UMB is a medical research university that has...
<p>This is a $580,000.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to F2G LTD, a for-profit organization, on September 29, 2021. The contract is for the creation and validation of a Patient Reported Outcome (PRO) instrument to assess health-related quality of life in patients with coccidioidomycosis. The contract has an ultimate completion date of October 30, 2024 and does not utilize a set-aside designation.</p>
The Department of Health and Human Services Food and Drug Administration awarded a definitive cost-no-fee contract for $2,370,000.00 to The Regents of the University of California, San Francisco (UCSF) to provide "RABBIT MODELS OF P. AERUGINOSA ACUTE PNEUMONIA, SEVERE SEPSIS,AND VENTILATOR-ASSOCAITED PNEUMONIA FO". The contract does not have a set-aside designation and was awarded on September 6, 2017, with a completion date of September 14, 2020. UCSF, a state-controlled institution...
This is a federal contract award made by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. government. The contract was awarded to Public Health England, a vendor located in Great Britain, United Kingdom. The contract is a delivery order under the BARDA Animal Model Development 2011-2016 contract vehicle, and is for "OTHER FUNCTIONS" related to animal model development. The contract has a ceiling value of $1,717,296.64 and a...
This federal contract award, valued at $399,988.00, was issued by the Food and Drug Administration (FDA) to Monash University, a non-profit research university in Australia. The contract is for a study titled "Bridging the Gap Between Urinary Tract Infection Pharmacokinetic/Pharmacodynamic In Vitro Models and the Optimization of Antibiotic Selection, Dosing Strategies, Clinical Breakpoints, and Novel Drug Development." The contract has a performance period through September 28, 2026...
This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Public Health England, a vendor located in Great Britain, United Kingdom. The contract is a Delivery Order under the Biological Animal Model Development 2017-2022 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle, which is managed by the Biomedical Advanced Research and Development Authority (BARDA). The contract has a potential value of...